Austres Pharmaceutical Private Limited
About Austres Pharmaceutical Private Limited
Data last updated:
Austres Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 27 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74900PN2014PTC150790. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Prashant Jayram Ambre and Sachin Jayram Ambre.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at Sr.No. 19/A/3 Unit No. 58 K.K. Market 6th Floor Dhankawadi, Pune, Maharashtra, India – 411043.
As per the financials filed for FY 2017, the company reported a revenue of ₹11.06 Lakh. For the same year it recorded a net profit of ₹52,861 (net margin 4.8%) and EBITDA of -₹1.1 Lakh (EBITDA margin -9.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Austres Pharmaceutical Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSr.No. 19/A/3 Unit No. 58 K.K. Market 6th Floor Dhankawadi, Pune, Maharashtra, India – 411043
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Austres Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Austres Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Austres Pharmaceutical Private Limited, buy the company report.
Financials of Austres Pharmaceutical Private Limited
FY 2019 filings availableAustres Pharmaceutical Private Limited reported revenue of ₹11.06 Lakh for FY 2017.
Financial Statement Summary
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹11.06 Lakh | ||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹1.1 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹52,861 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -9.9% | ||
| Net Profit Margin | 4.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Austres Pharmaceutical Private Limited, buy the company report.
Board of directors of Austres Pharmaceutical Private Limited
Austres Pharmaceutical has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prashant Jayram Ambre | Director | 20 Aug 2015 | 11 Years 2 Months | Current |
| Sachin Jayram Ambre | Director | 02 Sep 2014 | 12 Years 1 Months | Current |
| Nikhil Prakash Bhalerao Also directs: Final Choice Cars LLP, CSX Preowned Cars LLP | Director | 27 Feb 2014 | 12 Years 7 Months | Current |
Auditor
Austres Pharmaceutical Private Limited is audited by DDG & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DDG & Associates | FY 2017 | 131445W |
Shareholding
The shareholding of Austres Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Austres Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Austres Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Austres Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Austres Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Austres Pharmaceutical Private Limited, buy the company report.
Recent activity
Austres Pharmaceutical Private Limited has 6 board changes on record since 2014: 3 appointments and 3 cessations. The latest: Prashant Jayram Ambre ceased to be Additional Director on 30 Sep 2015.
Frequently asked questions
Austres Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 27 February 2014 (12+ years old) and is registered under CIN U74900PN2014PTC150790.
Austres Pharmaceutical has 3 current directors:
- Prashant Jayram Ambre - Director
- Sachin Jayram Ambre - Director
- Nikhil Prakash Bhalerao - Director
The latest financial statements of Austres Pharmaceutical on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from 2015 are in the company report.
No. Austres Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Austres Pharmaceutical is U74900PN2014PTC150790. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Austres Pharmaceutical was incorporated on 27 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Pune.
Prashant Jayram Ambre ceased to be Additional Director on 30 Sep 2015. Prashant Jayram Ambre was appointed as Director on 20 Aug 2015. Ramnath Santuji Dhumal ceased to be Director on 12 Jan 2015. Austres Pharmaceutical has 6 board changes on record in total.
The registered office of Austres Pharmaceutical is at Sr.No. 19A3 Unit No. 58 K.K. Market 6th Floor Dhankawadi, Pune, Maharashtra, India – 411043.
Austres Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Austres Pharmaceutical is compliant as of 20 July 2026. The company is actively filing with the Registrar of Companies.